Results provide proof-of-concept that ERK pathway reactivation might be an effective, biologically based therapy to prevent anthrax-induced lethality.

Outside of thrash metal circles, anthrax is treated with deadly seriousness. Caused by the bacterium Bacillus anthracis, this ...

Anthrax, an infectious disease caused by the bacterium Bacillus anthracis, is often treatable in its early stages. But once ...

Anthrax, an infectious disease caused by the bacterium Bacillus anthracis, is often treatable in its early stages. But once the disease has progressed ...

Anthrax, an infectious disease caused by the bacterium Bacillus anthracis, is often treatable in its early stages. But once ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued ...

The UK Health Security Agency has developed a toolkit to guide research and preparedness efforts in biosecurity.

On March 24, 1882, a German physician and researcher, Heinrich Hermann Robert Koch (1814-1910), announced the discovery of ...

Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has ...

Siberian Anthrax outbreak wasn’t just a freak accident—it was a warning shot. Thawing permafrost had awakened something ...

The anthrax-inducing bacillus anthracis bacteria that lives in animal blood can produce spores when it interacts with air, remaining viable for decades. In humans, anthrax can manifest cutaneously, ...

and B. anthracis (anthrax; a Bioterrorism Category A Threat-Level pathogen). Acurx's lead product candidate, ibezapolstat, for the treatment of C. difficile Infection is Phase 3 ready with plans ...